Objective: To map the current status of parameters and tools to assess quality of care related to peripheral venous catheter use in adults.
Methods: Scoping review, conducted in 2022 in the MEDLINE, LILACS, CINAHL and SCOPUS databases and with a publication time limit from 2013 to 2022.
Results: The sample consisted of 15 articles, summarized in the following categories: Indication, documentation and registration, coverage assessment, connection, stabilization and signs and symptoms inherent to the catheter. The use of a complete instrument, with the domains observed in this review, may have a positive impact on a more effective and safe clinical practice.
Conclusions: The present review mapped the evidence about the insertion and maintenance of peripheral venous catheters that can be improved with training of good practices and the quality of the team, regarding the use of tools, materials and instruments for the evaluation of care.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695046 | PMC |
| http://dx.doi.org/10.1590/0034-7167-2022-0578 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pitfalls in peripheral venous access under ultrasound guidance.
J Anesth
January 2025
Department of Anesthesiology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima City, Fukushima, 960-1295, Japan.
Intra-operative norepinephrine via peripheral venous catheter is safe: A short scientific report.
Eur J Anaesthesiol
February 2025
From the Division of Anaesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Management, Kantonsspital St. Gallen, St. Gallen (RS, MF), Institute of Anaesthesiology, Stadtspital Zürich Waid, Zürich (RS), Emergency Department, Kantonsspital Winterthur, Winterthur (CAR) and Division of Perioperative Intensive Care Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland (MF).
LncRNA LUCAT1 offers protection against human coronary artery endothelial cellular oxidative stress injury through modulating hsa-miR-6776-5p/LRRC25 axis and activating autophagy flux.
J Transl Med
December 2024
Department of Cardiovascular Medicine, The First Affiliated Hospital of Nanjing Medical University, Guangzhou Road 300, Nanjing, 210029, Jiangsu, China.
Background: Coronary artery disease (CAD) has become a dominant economic and health burden worldwide, and the role of autophagy in CAD requires further clarification. In this study, we comprehensively revealed the association between autophagy flux and CAD from multiple hierarchies. We explored autophagy-associated long noncoding RNA (lncRNA) and the mechanisms underlying oxidative stress-induced human coronary artery endothelial cells (HCAECs) injury.
View Article and Find Full Text PDFVascular Pain and Nurse Burden in Peripheral Administration of Fosaprepitant/Fosnetupitant: A Prospective Observational Study.
Anticancer Res
January 2025
Department of Nursing, Yamagata University Hospital, Yamagata, Japan.
Background/aim: Vascular pain associated with NK1 receptor antagonists, particularly fosaprepitant, remains a significant challenge in cancer chemotherapy. The present study investigated the incidence of vascular pain with the administration of fosaprepitant and fosnetupitant and assessed the psychological burden on nurses performing venipuncture.
Patients And Methods: We conducted a prospective observational study involving 115 cancer patients receiving NK1 receptor antagonists via peripheral venous catheters.
Aims: To determine patient and nursing factors associated with peripheral intravenous access success among hospitalised adults on medical-surgical units.
Design: A prospective, cross-sectional, correlational design was guided by STROBE.
Methods: Within a quaternary care hospital with multiple medical-surgical units, nurses who attempted intravenous access completed case report forms and medical records were reviewed to record 38 factors associated with intravenous access success.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!